IMicrobes

IMicrobes

IMicrobes Upgrades Natural Gas To Chemicals Using Synthetic Biology. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€436—655k (Dealroom.co estimates Dec 2014.)
Emeryville California (HQ)
  • Edit

Recent News about IMicrobes

Edit
More about IMicrobesinfo icon
Edit

iMicrobes is a pioneering company in the field of synthetic biology, dedicated to transforming greenhouse gases (GHGs) into sustainable materials. The company operates in the chemical manufacturing industry, focusing on providing cost-effective decarbonization solutions without compromising profitability. By using advanced engineered microbes, iMicrobes enables the use of methane—a greenhouse gas significantly more harmful than carbon dioxide—as a feedstock in chemical production, offering a lower-cost alternative to petroleum-based equivalents.

The business serves a diverse range of clients, including industrial manufacturers and companies committed to reducing their carbon footprint. iMicrobes' business model revolves around leveraging waste materials to create value, aligning with the principles of the circular economy. The company generates revenue through the sale of its sustainable materials and licensing its proprietary technology to other manufacturers.

iMicrobes is passionate about accelerating the transition to a low-carbon economy and believes in the power of science and technology to mitigate climate change. The company fosters a diverse, equitable, and inclusive workplace, prioritizing work-life balance and employee wellbeing.

Keywords: synthetic biology, greenhouse gases, sustainable materials, decarbonization, methane feedstock, chemical manufacturing, circular economy, cost-effective solutions, biotech innovation, low-carbon economy.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.